|
|
| |
|
|
|
|
|
|
| |
 |
Industry Expert |
|
| |
|
|
|
|
Mr. Yamada started his career at Yuki Gosei Yakuhin Kogyo Ltd. where
he developed production and separation process for bulk pharmaceutical
compounds derived from nucleic acids. Subsequently he developed
industrial scale separation processes for natural chemical compounds
for
the Japanese and Korean markets at Dow Chemical Japan and for US
market at the Dow Chemical Company (USA). He joined Ebara Corporation
and performed leadership role for new business development for air
purification system for semiconductor industry with novel ion exchange
fiber. After that, he managed marketing of biopharmaceutical purification
systems for the Japanese market at Amersham Pharmacia Biotech (currently
GE Healthcare Biosciences) .
In the recent past, he managed and delivered strategic consulting
for
technology companies including life science and pharmaceutical
industries at IBM Business Consulting Services KK.
|
|
|
|
|
Mr. Yamada received his B.S. in chemistry from Tokyo University of
Science and his MBA from Krannert Graduate School of Management,
Purdue University.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|